Pharmaceutical Business review

Banner gets FDA approval for nimodipine softgel capsules

Banner’s nimodipine 30mg capsules are the AB-rated generic equivalent of Bayer’s Nimotop 30mg capsules, and are indicated for the treatment of subarachnoid hemorrhage, a form of cerebral bleed and can be dispensed either in blister packaging or in bottles.

Banner has partnered with Heritage Pharmaceuticals, a New Jersey-based generics company, for the exclusive US sales and marketing rights.